loadpatents
Patent applications and USPTO patent grants for MORRIS; Arvia E..The latest application filed is for "mammalian cell culture".
Patent | Date |
---|---|
Mammalian Cell Culture App 20220185869 - FOLLSTAD; Brian D. ;   et al. | 2022-06-16 |
Mammalian cell culture Grant 11,292,829 - Follstad , et al. April 5, 2 | 2022-04-05 |
Mammalian Cell Culture App 20210061888 - FOLLSTAD; Brian D. ;   et al. | 2021-03-04 |
Mammalian Cell Culture App 20200407427 - FOLLSTAD; Brian D. ;   et al. | 2020-12-31 |
Use Of Interleukin-4 Antagonists And Compositions Thereof App 20190023798 - Armitage; Richard J. ;   et al. | 2019-01-24 |
Use Of Interleukin-4 Antagonists And Compositions Thereof App 20180171016 - ARMITAGE; Richard J. ;   et al. | 2018-06-21 |
Use Of Interleukin-4 Antagonists And Compositions Thereof App 20170137526 - ARMITAGE; Richard J. ;   et al. | 2017-05-18 |
Anti-interleukin-4 receptor antibodies Grant 9,587,026 - Armitage , et al. March 7, 2 | 2017-03-07 |
Method for culturing mammalian cells to improve recombinant protein production Grant 9,388,447 - Jerums , et al. July 12, 2 | 2016-07-12 |
Method For Culturing Mammalian Cells To Improve Recombinant Protein Production App 20160040207 - JERUMS; Matthew I. ;   et al. | 2016-02-11 |
Method for culturing mammalian cells to improve recombinant protein production Grant 9,133,493 - Jerums , et al. September 15, 2 | 2015-09-15 |
Dipeptides to enhance yield and viability from cell cultures Grant 9,012,178 - Kang , et al. April 21, 2 | 2015-04-21 |
Mammalian Cell Culture App 20140255993 - Follstad; Brian D. ;   et al. | 2014-09-11 |
Method For Culturing Mammalian Cells To Improve Recombinant Protein Production App 20140178984 - Jerums; Matthew I. ;   et al. | 2014-06-26 |
Use Of Interleukin-4 Antagonists And Compositions Thereof App 20140154267 - ARMITAGE; Richard J. ;   et al. | 2014-06-05 |
Anti-interleukin-4 receptor antibodies Grant 8,679,487 - Armitage , et al. March 25, 2 | 2014-03-25 |
Dipeptides To Enhance Yield And Viability From Cell Cultures App 20130189737 - Kang; Sohye ;   et al. | 2013-07-25 |
Use Of Interleukin-4 Antagonists And Compositions Thereof App 20110002913 - ARMITAGE; RICHARD J. ;   et al. | 2011-01-06 |
Method For Culturing Mammalian Cells To Improve Recombinant Protein Production App 20100221823 - McCoy; Rebecca E. ;   et al. | 2010-09-02 |
Monkey Immunoglobulin Sequences App 20070212301 - Aldrich; Teri ;   et al. | 2007-09-13 |
Methods and host cells for improved cell culture Grant 7,166,445 - Morris , et al. January 23, 2 | 2007-01-23 |
Regulation of translation for recombinant protein production Grant 7,091,004 - Morris , et al. August 15, 2 | 2006-08-15 |
Methods and host cells for improved cell culture App 20050170462 - Morris, Arvia E. ;   et al. | 2005-08-04 |
Methods and host cells for improved cell culture Grant 6,897,040 - Morris , et al. May 24, 2 | 2005-05-24 |
Expression augmenting sequence elements (EASE) for eukaryotic expression systems App 20030008345 - Morris, Arvia E. ;   et al. | 2003-01-09 |
Methods and host cells for improved cell culture App 20020160455 - Morris, Arvia E. ;   et al. | 2002-10-31 |
Methods and host cells for improved cell culture Grant 6,413,744 - Morris , et al. July 2, 2 | 2002-07-02 |
DNA encoding CD40 ligand, a cytokine that binds CD40 Grant 6,410,711 - Armitage , et al. June 25, 2 | 2002-06-25 |
Expression augmenting sequence elements (ease) for eukaryotic expression systems Grant 6,309,841 - Morris , et al. October 30, 2 | 2001-10-30 |
Expression augmenting sequence elements (EASE) for eukaryotic expression systems Grant 6,027,915 - Morris , et al. February 22, 2 | 2000-02-22 |
DNA encoding CD40 ligand, a cytokine that binds CD40 Grant 5,981,724 - Armitage , et al. November 9, 1 | 1999-11-09 |
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same Grant 5,962,406 - Armitage , et al. October 5, 1 | 1999-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.